Glia and their cytokines in progression of neurodegeneration
暂无分享,去创建一个
[1] R. Mrak,et al. Interleukin‐1 Expression in Different Plaque Types in Alzheimer's Disease: Significance in Plaque Evalution , 1995, Journal of neuropathology and experimental neurology.
[2] R. Mrak,et al. Glial‐Neuronal Interactions in Alzheimer Disease: Progressive Association of IL‐1α+ Microglia and S100β+ Astrocytes with Neurofibrillary Tangle Stages , 1997, Journal of neuropathology and experimental neurology.
[3] J. Price,et al. Cerebral amyloid deposition and diffuse plaques in ``normal'' aging , 1996, Neurology.
[4] J. Morley,et al. Age-related impairment in learning but not memory in SAMP8 female mice , 1995, Pharmacology Biochemistry and Behavior.
[5] J. Thome,et al. Advanced glycation endproducts in ageing and Alzheimer's disease , 1997, Brain Research Reviews.
[6] T. Takeda. [Senescence-accelerated mouse (SAM): with special reference to age-associated pathologies and their modulation]. , 1996, Nihon eiseigaku zasshi. Japanese journal of hygiene.
[7] W. Griffin,et al. Microglial inter leukin‐1α expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution , 1995, Neuropathology and applied neurobiology.
[8] J. Kimura,et al. Age-related decrease of nerve growth factor-like immunoreactivity in the basal forebrain of senescence-accelerated mice , 2004, Acta Neuropathologica.
[9] S. Barger,et al. Microglial activation by uptake of fDNA via a scavenger receptor , 2004, Journal of Neuroimmunology.
[10] E. Peskind,et al. Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease , 2001, Neurochemistry International.
[11] H. Wiśniewski,et al. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome , 1985, Annals of neurology.
[12] L. V. Van Eldik,et al. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. , 1994, Biochimica et biophysica acta.
[13] P. Yarowsky,et al. Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Graham,et al. Microglial interleukin-lα expression in human head injury: Correlations with neuronal and neuritic β-amyloid precursor protein expression , 1994, Neuroscience Letters.
[15] C. Kawas,et al. Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging , 1996, Neurobiology of Aging.
[16] D. Linnemann,et al. Regional changes in expression of NCAM, GFAP, and S100 in aging rat brain , 1994, Neurobiology of Aging.
[17] B. Mandavilli,et al. Neurons in the cerebral cortex are most susceptible to DNA‐damage in aging rat brain , 1996, Biochemistry and molecular biology international.
[18] S. Barger,et al. Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway , 2003, The Journal of Neuroscience.
[19] R. Mrak,et al. Neuritic plaque evolution in Alzheimer’s disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms , 1997, Acta Neuropathologica.
[20] R. Terry,et al. An immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex , 1987, Neurobiology of Aging.
[21] Gentleman,et al. Overexpression of S100β in Down’s syndrome: correlation with patient age and with β‐amyloid deposition , 1999 .
[22] D. Marshak,et al. Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe , 1992, Neurobiology of Aging.
[23] R. Mrak,et al. Increased Neuronal β‐Amyloid Precursor Protein Expression in Human Temporal Lobe Epilepsy: Association with Interleukin‐1α Immunoreactivity , 1994 .
[24] W. Streit,et al. The brain's immune system. , 1995, Scientific American.
[25] A. Cerami,et al. Macrophage receptor-mediated processing and regulation of advanced glycosylation endproduct (AGE)-modified proteins: role in diabetes and aging. , 1989, Progress in clinical and biological research.
[26] R. Mrak,et al. Interleukin‐1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer’s disease , 2002, Journal of leukocyte biology.
[27] P. Mecocci,et al. Oxidative damage to mitochondrial DNA shows marked age‐dependent increases in human brain , 1993, Annals of neurology.
[28] J. Roder,et al. Abnormal exploratory behavior in transgenic mice carrying multiple copies of the human gene for S100 beta. , 1995, Journal of psychiatry & neuroscience : JPN.
[29] R. Mrak,et al. Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation , 2001, Neurochemistry International.
[30] R. Mrak,et al. Human brain S100β and S100β mRNA expression increases with age: Pathogenic implications for Alzheimer's disease , 1996, Neurobiology of Aging.
[31] D. Graham,et al. Aging‐associated Changes in Human Brain , 1997, Journal of neuropathology and experimental neurology.
[32] R. Mrak,et al. Glial cytokines in Alzheimer's disease: review and pathogenic implications. , 1995, Human pathology.
[33] Laurie A. Miller,et al. Senile plaques in temporal lobe epilepsy , 1994, Acta Neuropathologica.
[34] C. Janus,et al. Spatial Exploration in Transgenic Mice Expressing Human β-S100 , 1995, Neurobiology of Learning and Memory.
[35] D. Marshak,et al. Purification and characterization of a neurite extension factor from bovine brain. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[36] D. Munoz,et al. Role of microglia in senile plaque formation , 1995, Neurobiology of Aging.
[37] W. Griffin,et al. Senescence-Accelerated Overexpression of S100β in Brain of SAMP6 Mice , 1998, Neurobiology of Aging.
[38] W. Griffin,et al. Distribution of interleukin‐1‐immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer’s disease , 1998, Neuropathology and applied neurobiology.
[39] W. Griffin,et al. Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.
[40] K. Higuchi,et al. Molecular genetic characterization of the senescence-accelerated mouse (SAM) strains. , 1994, Journal of gerontology.
[41] R. Mrak,et al. Correlation of Astrocytic S100β Expression with Dystrophic Neurites in Amyloid Plaques of Alzheimer's Disease , 1996, Journal of neuropathology and experimental neurology.
[42] W. Griffin,et al. S100β protein expression in Alzheimer disease: Potential role in the pathogenesis of neuritic plaques , 1994 .
[43] R. Mrak,et al. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer’s disease , 2001, Neurobiology of Aging.
[44] R. Mrak,et al. Enlarged and phagocytic, but not primed, interleukin-1α-immunoreactive microglia increase with age in normal human brain , 1998, Acta Neuropathologica.
[45] I. Mackenzie. Senile plaques do not progressively accumulate with normal aging , 2004, Acta Neuropathologica.
[46] R. Mrak,et al. Interleukin-1, neuroinflammation, and Alzheimer’s disease , 2001, Neurobiology of Aging.
[47] R. Mrak,et al. Glial Cytokines as Neuropathogenic Factors in HIV Infection: Pathogenic Similarities to Alzheimer's Disease , 1994, Journal of neuropathology and experimental neurology.
[48] T. Takeda. Senescence-Accelerated Mouse (SAM). A novel murine model of aging , 1994 .
[49] C. Masters,et al. Mitochondrial DNA polymorphism in substantia nigra , 1996, Journal of the Neurological Sciences.
[50] W. Griffin,et al. Life-long overexpression of S100β in Down’s syndrome: implications for Alzheimer pathogenesis , 1998, Neurobiology of Aging.
[51] R. Oppenheim,et al. S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo. , 1992, Journal of neurobiology.
[52] W. Griffin,et al. Overexpression of the Neurotrophic Cytokine S100β in Human Temporal Lobe Epilepsy , 1995, Journal of neurochemistry.
[53] W. Griffin,et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[54] P. Hof,et al. The neuropathological changes associated with normal brain aging. , 1996, Histology and histopathology.
[55] F. Suzuki,et al. Selective Increase in S‐100β Protein by Aging in Rat Cerebral Cortex , 1990 .
[56] W. Griffin,et al. Interleukin-1 Promotes Expression and Phosphorylation of Neurofilament and tau Proteins in Vivo , 2000, Experimental Neurology.
[57] M. Esiri,et al. Prevalence of Alzheimer plaques in AIDS , 1998, Journal of neurology, neurosurgery, and psychiatry.